31.99 -0.09 (-0.28%)
BMY
| Trade BMY now with |
Stock Details
Last Trade:31.99 Change:-0.09 (-0.28%) Prev Close:32.08 Open: 32.06 Days Range:31.80 – 32.13 52 Week Range: 24.97 - 35.44 Volume:6452345 P/E: 14.81EPS:2.16
View AllRecent Alerts 02/09/12
Recent Alert on 02/08/12 at 6:52am
Sanofi (SNY), Bristol-Myers Squibb (BMY) Get $442.2M Payment from Plavix Settlement
Sanofi (SNY), Bristol-Myers Squibb (BMY) Get $442.2M Payment from Plavix Settlement
Sanofi (NYSE: SNY) and Bristol-Myers Squibb Company (NYSE: BMY) announced that Apotex has made payment in the amount of $442,209,362 to Sanofi and Bristol-Myers Squibb to satisfy the damages ruling of the Plavix® (clopidogrel bisulfate) patent... Read More
Recent Alert on 02/08/12 at 6:52am
Sanofi (SNY), Bristol-Myers Squibb (BMY) Get $442.2M Payment from Plavix Settlement
Sanofi (SNY), Bristol-Myers Squibb (BMY) Get $442.2M Payment from Plavix Settlement
Recent Alert on 02/08/12 at 6:52am
Sanofi (SNY), Bristol-Myers Squibb (BMY) Get $442.2M Payment from Plavix Settlement
Sanofi (SNY), Bristol-Myers Squibb (BMY) Get $442.2M Payment from Plavix Settlement
View AllRecent Press Releases
Press Release on 02/08/12 at 3:19pm
Bristol-Myers Squibb to Present at Leerink Swann 2012 Global Healthcare Conference
Bristol-Myers Squibb to Present at Leerink Swann 2012 Global Healthcare Conference
Press Release on 02/08/12 at 1:30am
Sanofi and Bristol-Myers Squibb Collect Damages in Plavix Patent Litigation with Apotex
Sanofi and Bristol-Myers Squibb Collect Damages in Plavix Patent Litigation with Apotex
View AllRecent SEC Filings
No Recent SEC Filings Available
View AllRecent Blog Posts
Blog Posts on 02/09/12 at 7:30am
These Dividend-Paying, 'Recession-Proof,' 'Bond Substitute' Stocks Are Underperforming
These Dividend-Paying, 'Recession-Proof,' 'Bond Substitute' Stocks Are Underperforming
Blog Posts on 02/09/12 at 7:09am
Cramer Lightning Round - People's United Financial Is Like Watching Paint Dry (2/8/12)
Cramer Lightning Round - People's United Financial Is Like Watching Paint Dry (2/8/12)


